← Alle mensen

AD

Alessandro Di Federico

6 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Chemo-immunotherapie ± VEGF-remming na falen van EGFR-TKI bij EGFR-gemuteerd NSCLC: meta-analyse op IPD-niveau

JTO clinical and research reports · 1 april 2026

TTF-1-expressie bij longadenocarcinoom: klinisch-pathologische, genomische en immunofenotypische correlaties

Journal of Thoracic Oncology · 12 februari 2026

Long-term totale overleving with dual CTLA-4 and PD-L1 or PD-1 blockade and biomarker-based subgroup analyses in pati...

The Lancet. Oncology · 1 november 2025

MAPK Pathway-Activating Alteration and Immunotherapy Efficacy in Squamous Cell Lung Carcinoma: Results from the Geran...

Clinical cancer research : an official journal of the American Association for Cancer Research · 17 maart 2025

Improved Event-Free Survival After Complete or Major Pathologic Response in Patiënten met Resectable NSCLC Treated Wi...

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 1 maart 2025

Voorspellers van overleving bij IO en chemo-IO bij NSCLC: meta-analyse

Journal of the National Cancer Institute · 10 januari 2023